A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma receives Life Sciences Nordic Stars Award

Herantis Pharma receives Life Sciences Nordic Stars Award Herantis Pharma Plc Press release 15 Sep 2017 at 8:30 am Herantis…

Read More

Herantis Pharma Plc's half year financial report January 1 - June 30, 2017 (unaudited)

Herantis Pharma PlcCompany release August 29, 2017 at 9:00am Drug development progresses towards randomized trials Herantis Pharma Plc's half year…

Read More

Herantis Pharma's Manager's Transactions

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 22 Aug 2017 at 9:00 am Herantis Pharma Oyj - Managers'…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.